clinical trial · NCT07165652
Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog®, and EU-Humalog®
Xentria, Inc.·phase1·completed·n = 54
Healthy Male Adult VolunteersNKF-INS(L)US-Humalog®EU-Humalog®
brief summary
Study to demonstrate pharmacokinetic and pharmacodynamic similarity between NKF-INS(L), US-Humalog®, and EU-Humalog®
started
Oct 13, 2025
primary completion
Mar 2, 2026
completion
Mar 2, 2026
last updated
Mar 6, 2026
detailed description
A single center, single-dose, double-blind, randomized, three-period, three-treatment, six-sequence, crossover study to demonstrate pharmacokinetic and pharmacodynamic similarity between NKF-INS(L), US-Humalog®, and EU-Humalog® using the euglycemic clamp technique in healthy male adult volunteers
official title
A Single Center, Single-dose, Double-blind, Randomized, Three-period, Three-treatment, Six-sequence, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog®, and EU-Humalog® Using the Euglycemic Clamp Technique in Healthy Male Adult Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol